Join
Live feed
·
INSIDERFilingvia Quantisnow
CNS Pharmaceuticals Inc. logo

SEC Form 4: Downs Christopher bought $34,177 worth of shares (27,000 units at $1.27), increasing direct ownership by 276% to 36,772 units

ByQuantisnow·Wall Street's wire, on your screen.
CNSP· CNS Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNSP (CNS Pharmaceuticals Inc.) and more on Quantisnow.